GW Pharmaceuticals PLC | Balance Sheet
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
61,648.90
266,664.60
355,772.40
486,335.20
323,572.40
591,500.10
Total Accounts Receivable
6,267.10
10,816.30
21,161.10
30,190.10
41,978.90
13,290.10
Inventories
7,548.00
7,744.20
7,204.20
5,518.20
5,694.00
51,007.30
Other Current Assets
2,685.00
706.80
2,338.80
3,425.50
-
10,967.10
Total Current Assets
78,149.00
285,932.00
386,476.30
525,468.90
371,245.30
666,764.50
Net Property, Plant & Equipment
8,867.80
18,868.60
43,523.30
50,592.20
58,584.50
89,430.50
Intangible Assets
8,437.10
8,446.20
8,263.00
7,584.90
8,397.40
9,376
Total Assets
95,453.90
313,695.80
438,895.80
588,676.90
446,655.40
773,951.10
ST Debt & Current Portion LT Debt
161.90
204.30
695.30
1,371.70
796.90
Accounts Payable
5,494.60
3,796.70
5,748.50
4,459.50
7,791.00
Income Tax Payable
-
-
554.40
1,147.00
1,124.30
Other Current Liabilities
14,943.80
24,091.90
35,063.40
38,421.80
39,216.40
Total Current Liabilities
20,600.40
28,092.90
42,061.60
45,400.10
48,928.60
Long-Term Debt
3,085.00
2,887.30
15,124.80
18,682.20
17,055.10
Provision for Risks & Charges
-
-
-
-
14.80
Deferred Taxes
-
449.10
633.20
5,031.00
8,428.20
Other Liabilities
14,438.60
25,627.10
10,186.70
6,956.20
7,443.50
Total Liabilities
38,123.90
56,607.30
67,373.10
71,038.40
73,441.90
Common Equity (Total)
57,330.00
257,088.50
371,522.70
517,638.50
373,213.50
Total Shareholders' Equity
57,330.00
257,088.50
371,522.70
517,638.50
373,213.50
Total Equity
57,330.00
257,088.50
371,522.70
517,638.50
373,213.50
Liabilities & Shareholders' Equity
95,453.90
313,695.80
438,895.80
588,676.90
446,655.40
About GW Pharmaceuticals
View Profile
